Emerging From Stealth Mode, Tesselate Bio Looks To Develop Next-Gen Synthetic Lethality Drugs

 
• By Andrew McConaghie
  
Zuidas, Amsterdam
The new biotech has been set up with funding from BioGeneration Ventures and Forbion and is headquartered just outside Amsterdam, Netherlands.
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Start-Ups & SMEs

More from Business